Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acamprosate for Methamphetamine Dependence
NCT00571922Phase 2Completed
- Sponsor
- NYU Langone Health
- Start
- Jul 2007
- Primary completion
- Nov 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in methamphetamine use disorder (MUD) comparing Acamprosate with Placebo (2 arms). Primary endpoint: Methamphetamine Abstinence. Started Jul 2007; status: completed.
02
Drugs
acamprosate
03
Conditions
methamphetamine use disorder (MUD)
Beyond the preview
Go deeper on NCT00571922.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00571922.